Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation
about
Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.N, N'-Olefin functionalized bis-imidazolium gold(I) salt is an efficient candidate to control keratitis-associated eye infection.Targeting the cyclin-binding groove site to inhibit the catalytic activity of CDK2/cyclin A complex using p27(KIP1)-derived peptidomimetic inhibitorsStructure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics.Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D₂ and D₃ ReceptorsDopamine Genetics and Function in Food and Substance Abuse.Effects of the neurotensin NTS₁ receptor agonist PD149163 on visual signal detection in rats.Individualizing clozapine and risperidone treatment for schizophrenia patients.Insights into the structural biology of G-protein coupled receptors impacts drug design for central nervous system neurodegenerative processes.Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.Homology modeling, molecular dynamic simulation, and docking based binding site analysis of human dopamine (D4) receptor.Combined pharmacophore modeling, 3D-QSAR, homology modeling and docking studies on CYP11B1 inhibitors.Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.Novel therapeutics in glaucoma management.Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design.In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.Functional roles of T3.37 and S5.46 in the activation mechanism of the dopamine D1 receptor.
P2860
Q27325455-D1DD6D93-220B-4D69-A420-1A565491D1C6Q34647993-BA510B2E-22D0-4284-A0A5-64ADDA9342CAQ35542088-135FF0C0-33DE-4516-B146-5E54ABF391FFQ35962179-ACAADBEA-5B82-48B7-B9A3-AD5A4C0E240DQ36642828-387A65EB-0F96-4BA1-A5D6-E42557C00FA0Q36718951-CA3983B1-F95A-4B67-B27E-7CA71ED30F62Q37389307-DFDAA6A2-0932-43AC-8D46-5746D447F2F5Q38170458-1319F871-C20F-4DD4-A97F-31E43E010C38Q38247995-05C333ED-33CD-4E53-940F-80748D21D002Q38911479-4F9E6B4F-E4E8-4E64-B63F-3B36E153B626Q39043434-2A083C3D-CC75-4AE9-9C83-6E11F27D394CQ41588686-F8170D20-AA58-45F9-9344-FF38F1322185Q47670909-A8B34C35-76F9-4732-88F1-FA0A2086A463Q50023818-F9E49320-E8EE-4225-B937-EB8E6CEC2BA6Q52654614-2E414805-0848-4960-B958-1164FF201590Q52665081-32F29013-2083-4898-95AB-D788B5316F10Q52694045-09E0EDB7-82C1-4EFD-A9BB-0D4B4B114B09
P2860
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Homology modeling of dopamine ...... inement and docking evaluation
@ast
Homology modeling of dopamine ...... inement and docking evaluation
@en
Homology modeling of dopamine ...... inement and docking evaluation
@nl
type
label
Homology modeling of dopamine ...... inement and docking evaluation
@ast
Homology modeling of dopamine ...... inement and docking evaluation
@en
Homology modeling of dopamine ...... inement and docking evaluation
@nl
prefLabel
Homology modeling of dopamine ...... inement and docking evaluation
@ast
Homology modeling of dopamine ...... inement and docking evaluation
@en
Homology modeling of dopamine ...... inement and docking evaluation
@nl
P2860
P50
P1433
P1476
Homology modeling of dopamine ...... inement and docking evaluation
@en
P2860
P304
P356
10.1371/JOURNAL.PONE.0044316
P407
P50
P577
2012-01-01T00:00:00Z